Demographic and clinical characteristics | Survived without LT n = 54 | Died without LT n = 186 | Underwent LT n = 100a | P-value |
---|---|---|---|---|
Age | 54 ± 10 | 57 ± 9 | 56 ± 10 | 0.14 |
Gender (male) (%) | 43 | 64 | 71 | 0.002 |
Race (%) | ||||
White | 87 | 91 | 91 | 0.4 |
Black | 4 | 4 | 6 | |
Hispanic | 6 | 4 | 1 | |
Asian | None | 1 | 1 | |
Other | 3 | None | 1 | |
Body mass index | 28 ± 6 | 30 ± 7 | 30 ± 6 | 0.4 |
Etiology of liver disease (%) | ||||
Alcohol | 29 | 34 | 30 | 0.001 |
Alcohol and viral | 12 | 21 | 10 | |
Viral | 29 | 18 | 13 | |
Autoimmune | 9 | 2 | 17 | |
Fatty liver | 19 | 20 | 24 | |
Cryptogenic | 2 | 2 | 3 | |
MELD | 13.9 ± 4.4 | 17.7 ± 7.1 | 18.1 ± 5.9 | < 0.001 |
Hepatocellular carcinoma (%) | 7 | 27 | 25 | 0.01 |
CCI (mean) | 0.6 ± 0.9 | 1.1 ± 1.3 | 0.6 ± 0.8 | < 0.001 |
(median (IQR)) | 0 (IQR 0,1) | 1 (IQR 0,2) | 0 (IQR 0,1) | |
CCI Category (%) | ||||
CCI = 0 | 59 | 34 | 56 | 0.001 |
CCI = 1–2 | 33 | 50 | 38 | |
CCI > 2 | 8 | 16 | 6 | |
CIRCOM | 0.6 ± 0.8 0 (IQR 0,1) | 1.1 ± 1.3 1 (IQR 0,2) | 0.4 ± 0.9 0 (IQR 0,1) | < 0.001 |